ENAapplication/xmlftp.sra.ebi.ac.uk/vol1/fastq/SRR997/000/SRR9971400/SRR9971400_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR997/003/SRR9971393/SRR9971393_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR997/001/SRR9971401/SRR9971401_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR997/009/SRR9971399/SRR9971399_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR997/005/SRR9971395/SRR9971395_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR997/004/SRR9971404/SRR9971404_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR997/002/SRR9971402/SRR9971402_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR997/001/SRR9971401/SRR9971401_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR997/000/SRR9971400/SRR9971400_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR997/004/SRR9971394/SRR9971394_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR997/003/SRR9971403/SRR9971403_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR997/009/SRR9971399/SRR9971399_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR997/005/SRR9971395/SRR9971395_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR997/003/SRR9971403/SRR9971403_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR997/002/SRR9971402/SRR9971402_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR997/007/SRR9971397/SRR9971397_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR997/007/SRR9971397/SRR9971397_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR997/003/SRR9971393/SRR9971393_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR997/008/SRR9971398/SRR9971398_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR997/006/SRR9971396/SRR9971396_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR997/004/SRR9971394/SRR9971394_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR997/004/SRR9971404/SRR9971404_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR997/008/SRR9971398/SRR9971398_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR997/006/SRR9971396/SRR9971396_2.fastq.gzprimaryOK200GenomicsThe Mayo Clinichttps://www.ebi.ac.uk/ena/browser/view/PRJNA560339Homo sapiensThis study aims to compare the genetic profile of fibrotic and non-fibrotic human knee capsular tissue in an effort to identify possible molecular pathways responsible for the development of AF. RNA sequencing (RNA-seq) and bioinformatics were used to define differentially expressed genes (DEGs) and molecular pathways linked to joint stiffening. Gene expression profiling revealed a distinct clustering of each patient group by principal component analysis, hierarchical clustering and similarity matrix analysis. Three prospectively-collected, matched patient cohorts were used to formally describe gene expression signatures of AF patients. The findings define molecular and pathological markers of AF, as well as novel potential targets for pre-diagnosis and pharmacological treatment of AF patients. Overall design: Examination of pTKA (n=4), rTKA-A (n=4) and rTKA-NA (n=4) tissues for molecular markers.ENARNA, human being, histopathology, RNA Sequence Analyses, RNA Sequence Determination, Analyses, Determination, RNA Sequence Determinations, RNA Sequence Analysis, Sequence Determination, Pathologies, RNA Sequence, RNA., RNA Sequencing, cytopathology, Analysis, biopsy, knee region, man, Sequence Determinations, human, Sequencing, Determinations, Sequence AnalysesRNA, human being, histopathology, RNA Sequence Analyses, RNA Sequence Determination, Analyses, Determination, RNA Sequence Determinations, RNA Sequence Analysis, Sequence Determination, Pathologies, RNA Sequence, RNA., RNA Sequencing, cytopathology, Analysis, biopsy, knee region, man, Sequence Determinations, human, Sequencing, Determinations, Sequence Analyses0.00.00.00.00.0falseMolecular Pathology of Human Knee Arthrofibrosis Defined by RNA SequencingMolecular Pathology of Human Knee Arthrofibrosis Defined by RNA Sequencing2022-06-152019-08-17PRJNA560339GSE135854321453789606